Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ALTR stock price vs CI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CI's multiple
Needs CI P/E.
Implied fair value · at ALTR's multiple
Needs ALTR P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ALTR FY 2024 (ended Dec 31, 2024) · CI FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
ALTAIR ENGINEERING INC. · implied price per share
Bear
$8.85
Base
$10.42
Bull
$11.98
The Cigna Group · implied price per share
Bear
-$164.88
Base
-$193.98
Bull
-$223.08
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.22x
0.75x
Net debt / EBITDA
Leverage against operating earnings
-4.39x
2.09x
Cash and equivalents
Liquid reserves on the balance sheet
$561.90M
$8.73B
Total debt
Interest-bearing obligations outstanding
$188.65M
$31.46B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ANSYS INC
ALTR vs ANSS
PTC INC.
ALTR vs PTC
BENTLEY SYSTEMS INC
ALTR vs BSY
Autodesk, Inc.
ALTR vs ADSK
ORACLE CORP
ALTR vs ORCL
UNITEDHEALTH GROUP INC
ALTR vs UNH
CVS HEALTH Corp
ALTR vs CVS
HUMANA INC
ALTR vs HUM
CENTENE CORP
ALTR vs CNC
WEST PHARMACEUTICAL SERVICES INC
ALTR vs WST
BAXTER INTERNATIONAL INC
ALTR vs BAX
Live quote
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe ALTR can convert its very high gross margin into materially better operating and free-cash-flow generation, then ALTR looks worth holding or adding because its balance sheet is stronger and the DCF range of $5.08-$6.88 sits above the low end of CI-implied range.
The stated CI-implied value for ALTR is $2.12-$17.75 versus a DCF range of $5.08-$6.88, which suggests the market could justify a wide spread depending on the multiple set used. Because ALTR has no provided current price and no direct P/E, P/S, or EV-based multiples, the valuation gap cannot be cleanly anchored to a single basis.
Supporting Metrics
